Pharmakure's key focus is Alzheimer's Disease, where no effective
treatments exist, leading to enormous human and financial cost

Our strategy is to discover new uses for known compounds
or drugs through our phenotypic screening methods

This strategy offers great promise for quickly bringing
new therapeutic options to Alzheimer's patients

PharmaKure already owns intellectual property on
one drug discovered by our screening approach

This first drug is at the stage of pre-Phase 1
(first time in humans) assessment